NASDAQ:CANC Tema Oncology ETF (CANC) Price, Holdings, & News $37.97 -0.15 (-0.39%) As of 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock About Tema Oncology ETF (NASDAQ:CANC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Tema Oncology ETF alerts:Sign Up Key Stats Today's Range$37.65▼$38.2050-Day Range$34.84▼$39.8252-Week Range$22.48▼$39.95Volume6,836 shsAverage Volume32,493 shsMarket Capitalization$178.08 millionAssets Under Management$176.17 millionDividend YieldN/ANet Expense Ratio0.75%Aggregate RatingModerate Buy ETF Overview The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema. Read More Tema Oncology ETF ExpensesTypeCANCTheme ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.99%0.57%0.57%0.54%0.53%Other Expenses0.00%0.57%0.55%0.51%0.55%Total Expense0.99%0.73%0.76%0.73%0.73%Fee Waiver-0.24%-0.74%-0.64%-0.50%-0.61%Net Expense0.75%0.60%0.63%0.62%0.60% Receive CANC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tema Oncology ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CANC ETF News HeadlinesTema ETFs Surpasses $2 Billion in AUM in Under Three YearsApril 16, 2026 | marketwatch.comCANC: I Give A Hold Rating To This ETF That Invests In Cancer-Fighting StocksApril 10, 2026 | seekingalpha.comYou're not getting into the SpaceX IPO. Do this instead.The SpaceX IPO is expected to price at $1.75 trillion - and retail investors won't get an allocation. Banks and insiders have already locked it up. But there is one small, publicly traded company that builds the critical infrastructure SpaceX cannot operate without. Dylan Jovine is releasing the ticker name today at no cost.May 14 at 1:00 AM | Behind the Markets (Ad)Healthcare stocks are red-hot. Here are 3 picks from a fund manager up 41% this year.December 4, 2025 | msn.comTema's Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 PerformanceDecember 2, 2025 | businesswire.comSee More Headlines CANC ETF - Frequently Asked Questions How have CANC shares performed this year? Tema Oncology ETF's stock was trading at $34.72 at the beginning of the year. Since then, CANC stock has increased by 9.3% and is now trading at $37.95. Who are Tema Oncology ETF's major shareholders? Tema Oncology ETF's top institutional investors include Roxbury Financial LLC (0.02%). How do I buy shares of Tema Oncology ETF? Shares of CANC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Tema Oncology ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Tema Oncology ETF investors own include Archer Aviation (ACHR), Advanced Micro Devices (AMD), Beam Therapeutics (BEAM), CRISPR Therapeutics (CRSP), Lockheed Martin (LMT), NiCE (NICE) and Intellia Therapeutics (NTLA). Fund Details IssuerTema Global Fund NameTema Oncology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:CANC Inception Date8/15/2023 Fund ManagerDavid Song WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelDeveloped Markets RegionGlobal Number of Holdings57 Fund Statistics Assets Under Management$176.17 million Average Daily Volume$0.00 Discount/Premium0.07% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorTema ETFs LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerVirtu Financial Options OptionableN/A Short Interest8,600 shs Miscellaneous Outstanding Shares4,690,000Beta0.74 Creation Unit10,000 Creation Fee$500.00 7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Top 10 CANC HoldingsRevolution Medicines (NASDAQ:RVMD)Holding Weight: 7.31%Eli Lilly and Company (NYSE:LLY)Holding Weight: 4.25%Immunome (NASDAQ:IMNM)Holding Weight: 4.21%Cogent Biosciences (NASDAQ:COGT)Holding Weight: 4.08%Roche (OTCMKTS:RHHBY)Holding Weight: 4.07%Novartis AGHolding Weight: 4.00%Celcuity (NASDAQ:CELC)Holding Weight: 3.93%AstraZeneca PLCHolding Weight: 3.50%Merck & Co., Inc. (NYSE:MRK)Holding Weight: 3.43%Bristol Myers Squibb (NYSE:BMY)Holding Weight: 3.34%Full Holdings DetailsCANC Sector ExposureCANC Industry Exposure This page (NASDAQ:CANC) was last updated on 5/14/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredPeptide Company Lands Exclusive MMA Wellness PartnershipA publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...The Tomorrow Investor | SponsoredI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...Porter & Company | SponsoredMillionaire warns: Move your money before May 15Larry Benedict - the trader who generated $274 million in client profits and beat the S&P 500 by 18 times in 2...Brownstone Research | SponsoredElon’s Biggest Launch Ever: 15x Bigger Than SpaceXThe Man Who Called Nvidia Before It Soared 1,000% Issues New Elon Musk BUY Alert Luke Lango was ranked Amer...InvestorPlace | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CANC Stock Alerts